This article is more than 5 years old. Information may no longer be current.

Alcon launches DisCoVisc in Brazil

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

SAO PAULO, Brazil — Alcon introduced its latest ophthalmic viscosurgical device to the Brazilian market here at the World Ophthalmology Congress, company officials said.

DisCoVisc (sodium chondroitin sulfate 4%, sodium hyaluronate 1.65%, Alcon) is intended for use during all stages of anterior segment surgery, according to a press release. The company calls the product a viscous dispersive, meaning it marries properties of cohesive and dispersive viscoelastic agents that are currently on the market.

DisCoVisc acts as a cohesive in that it maintains the shape of the anterior chamber during phacoemulsification and is easy to remove, according to Alcon. At the same time, the dispersive quality allows the product to stay in the eye and protect the endothelium, the company said.